Document is current
Any future updates will be listed below
-
Authors
Özcebe, Hilal
Üner, Sarp
Karadag, Ozge
Daryani, Achraf
Gershuni, Olga
Czabanowska, Katarzyna
Brand, Helmut
Erdsiek, Fabian
Aksakal, Tuğba
Brzoska, Patrick https://orcid.org/0000-0001-6489-5198
-
Funding
Funding for this research was provided by:
European Commission (2015-1-TR01-KA204-022393)
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 30 January 2022
Accepted: 1 February 2022
First Online: 15 February 2022
Declarations
:
: The study was reviewed and approved by the Non-Interventional Clinical Research Ethics Board of Hacettepe University (No. GO 6/382–27) in Turkey, the Ethics Committee of the Faculty of Behavioral and Social Sciences of Chemnitz University of Technology (No. V-144-AR-PB-Antibiotic-10062016) in Germany, the Medical Ethics Review Committee of Maastricht University and the University Medical Centre Maastricht (No.16–4-213.1/ab) in the Netherlands and by the Regional Ethics Committee of Uppsala University (No. 2016/377) in Sweden. In all four countries, individuals provided verbal consent prior to their participation in the study. This procedure was approved by the respective ethics committees and is commonly adopted in the four countries for qualitative interviews with health professionals and other non-vulnerable individuals.
: Not applicable.
: The authors declare that there are no competing interests.
